lot-t5-small-filter / README.md
alpeshsonar's picture
Update README.md
37ef975 verified
|
raw
history blame
4.21 kB
metadata
language:
  - en
widget:
  - text: >-
      Extract lots from given text.

      1. Age 18 to 75 years, inclusive. 2. Study participants must have a
      diagnosis of symptomatic multiple myeloma requiring systemic therapy and
      are eligible for the planned ASCT. 3. Untreated bone marrow sample was
      shipped to Princess Margaret Hospital for MRD assay. 4. Must have been
      treated with a velcade-based induction regimen. No limit to the number of
      cycles of induction. 5. Study participants in whom the minimum stem cell
      dose of 2.0 x 106 cluster of differentiation (CD)34+ cells/kg has been
      collected. 6. Eastern Cooperative Oncology Group (ECOG) Performance Status
      of 0-2. 7. Negative beta-human chorionic gonadotropin (β-HCG) pregnancy
      test in all females of child-bearing potential (FOCBP). 8. Ability to
      provide written informed consent prior to initiation of any study-related
      procedures, and ability, in the opinion of the Principal Investigator, to
      comply with all requirements of the study.
    example_title: Translation
  - text: >-
      Extract lots from given text.

      age ≥18 years * patients with de novo or secondary AML, with an
      unfavorable or intermediate karyotype (according to the 2017 ELN
      classification), or patients with relapsing AML who may receive
      second-line treatment * not candidates for intensive induction, for the
      following reasons* 75 years or  18 to 74 years and at least one of the
      following comorbidities: PS  2 or a history of heart failure requiring
      treatment or LVEF  50% or chronic stable angina or FEV1  65% or DLCO 
      65% or creatinine clearance <45 ml / min; or liver damage with total
      bilirubin> 1.5 N or other comorbidities that the hematologist considers
      incompatible with intensive treatment * ineligible for a classic
      allogeneic hematopoietic stem cell transplant due to the presence of
      co-morbidities or too high a risk of toxicity >70 years old or at least
      one of the following comorbidities: PS  2 or a history of heart failure
      requiring treatment or LVEF  50% or chronic stable angina or FEV1  65%
      or DLCO  65% or creatinine clearance <45 ml / min; or liver damage with
      total bilirubin> 1.5 N * may receive chemotherapy with hypomethylating
      agents have a partially compatible (haplo-identical) major family donor
      (≥18 years old) eligible for lymphocyte donation.
    example_title: Example 2
library_name: transformers
tags:
  - lot
  - line of therapy
license: apache-2.0
pipeline_tag: text2text-generation

Uses

from transformers import T5Tokenizer, T5ForConditionalGeneration

tokenizer = T5Tokenizer.from_pretrained("alpeshsonar/lot-t5-small-filter")
model = T5ForConditionalGeneration.from_pretrained("alpeshsonar/lot-t5-small-filter")

input_text = """"Extract lots from given text.
* age ≥18 years * patients with de novo or secondary AML, with an unfavorable or intermediate karyotype (according to the 2017 ELN classification), or patients with relapsing AML who may receive second-line treatment * not candidates for intensive induction, for the following reasons* 75 years or ≥ 18 to 74 years and at least one of the following comorbidities: PS ≥ 2 or a history of heart failure requiring treatment or LVEF ≤ 50% or chronic stable angina or FEV1 ≤ 65% or DLCO ≤ 65% or creatinine clearance <45 ml / min; or liver damage with total bilirubin> 1.5 N or other comorbidities that the hematologist considers incompatible with intensive treatment * ineligible for a classic allogeneic hematopoietic stem cell transplant due to the presence of co-morbidities or too high a risk of toxicity >70 years old or at least one of the following comorbidities: PS ≥ 2 or a history of heart failure requiring treatment or LVEF ≤ 50% or chronic stable angina or FEV1 ≤ 65% or DLCO ≤ 65% or creatinine clearance <45 ml / min; or liver damage with total bilirubin> 1.5 N * may receive chemotherapy with hypomethylating agents have a partially compatible (haplo-identical) major family donor (≥18 years old) eligible for lymphocyte donation.
"""
input_ids = tokenizer(input_text, return_tensors="pt").input_ids
outputs = model.generate(input_ids,max_new_tokens=1024)
print(tokenizer.decode(outputs[0],skip_special_tokens=True))